Sanofi India Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sanofi India Limited's yearly results (2022–2025), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 0 of 3. Less steady than almost all Healthcare companies in India.
- Debt Due Cover Ratio: Debt due within a year is covered 106.9 times by its yearly operating cash. Higher than 98% of Healthcare companies in India.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 11.7 times. Higher than 96% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹84Over the last 3 years, every ₹100 of reported profit came with ₹84 of operating cash.
Lower than 70% of Healthcare companies in India.
Self-Funding Ratio
11.7×Over the last 3 years its own operating cash covered its investment spending (capex) 11.7 times.
Higher than 96% of Healthcare companies in India.
Cash Locked Ratio
₹13For every ₹100 of sales, ₹13 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹6 tied up three years earlier.
Less money tied up than 70% of Healthcare companies in India.
Growth quality
Steadiness Ratio
1/3 · 0/3Sales grew in 1 of the last 3 years; profit grew in 0 of 3.
Less steady than almost all Healthcare companies in India.
Growth Efficiency Ratio
—Sales fell 33%
Sales fell 33% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-33% / -39%In 3 years sales changed by -33% while total assets changed by -39%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
106.9×Debt due within a year is covered 106.9 times by its yearly operating cash.
Higher than 98% of Healthcare companies in India.
Cash Cushion Ratio
+4%Cash, after subtracting all debt, equals 4% of its market value (net cash).
Higher than 77% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 88% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 86% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Sanofi India Limited owes ₹0.41 for every ₹1 it owns. Net profit fell 21% in the year to Dec 2025, and shrank 19% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Dec 2025.
P/E ratio
20.1Investors pay ₹20.1 for every ₹1 of Sanofi India Limited's yearly profit, lower than 83% of Healthcare companies in India.
P/B ratio
7.89The share price is 7.89 times Sanofi India Limited's book value per share, higher than 77% of Healthcare companies in India.
Market cap
₹6,520 CrThe total market value of all of Sanofi India Limited's shares at today's price (share price × number of shares), larger than 54% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹826 CrWhat Sanofi India Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
₹358.65Net worth divided by the number of shares. The share price of ₹2,831 is 7.9 times this, which is the P/B above.
Return on equity (ROE)
40.3%Sanofi India Limited earned 40.3% on its shareholders' money over the last year, higher than 96% of Healthcare companies in India.
Owes vs Owns
0.41×Sanofi India Limited owes ₹0.41 for every ₹1 it owns (low), higher than 62% of Healthcare companies in India.
Dividend yield
4.18%Sanofi India Limited pays 4.18% of its share price as dividends a year, higher than almost all dividend-paying Healthcare companies in India.
Revenue growth
-8%Revenue fell 8% in the year to Dec 2025, and shrank 13% a year on average over 3 years.
Profit growth
-21%Net profit fell 21% in the year to Dec 2025, and shrank 19% a year on average over 3 years.
Profit margin
17.9%Sanofi India Limited keeps ₹18 of every ₹100 of revenue as net profit.
Cash quality
1.3×Cash from Sanofi India Limited's business was 1.3× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
267.1×Sanofi India Limited's operating profit covered its interest costs 267.1 times in the year to Dec 2025.
Cash vs debt
Net cashSanofi India Limited held ₹245 Cr more cash than debt (net cash) at Dec 2025.
Questions
What is Sanofi India Limited's P/E ratio?
Investors pay ₹20.1 for every ₹1 of Sanofi India Limited's yearly profit, lower than 83% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sanofi India Limited: ₹6,520 Cr ÷ ₹826 Cr (30 Jun 2026) = 7.9.
What is Sanofi India Limited's return on equity?
Sanofi India Limited earned 40.3% on its shareholders' money over the last year, higher than 96% of Healthcare companies in India.
How much does Sanofi India Limited owe compared with what it owns?
Sanofi India Limited owes ₹0.41 for every ₹1 it owns (low), higher than 62% of Healthcare companies in India.
Does Sanofi India Limited pay a dividend?
Yes. Sanofi India Limited pays 4.18% of its share price as dividends a year, higher than almost all dividend-paying Healthcare companies in India.
Is Sanofi India Limited's revenue growing?
Revenue fell 8% in the year to Dec 2025, and shrank 13% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.